tiprankstipranks
Trending News
More News >
PreveCeutical Medical (TSE:PREV)
:PREV

PreveCeutical Medical (PREV) Price & Analysis

Compare
11 Followers

PREV Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

18.70%81.30%
18.70% Insiders
Mutual Funds
― Other Institutional Investors
81.30% Public Companies and
Individual Investors

PREV FAQ

What was PreveCeutical Medical ’s price range in the past 12 months?
PreveCeutical Medical lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.
    What is PreveCeutical Medical ’s market cap?
    PreveCeutical Medical ’s market cap is C$19.97M.
      When is PreveCeutical Medical ’s upcoming earnings report date?
      PreveCeutical Medical ’s upcoming earnings report date is Aug 21, 2025 which is in 65 days.
        How were PreveCeutical Medical ’s earnings last quarter?
        Currently, no data Available
        Is PreveCeutical Medical overvalued?
        According to Wall Street analysts PreveCeutical Medical ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does PreveCeutical Medical pay dividends?
          PreveCeutical Medical does not currently pay dividends.
          What is PreveCeutical Medical ’s EPS estimate?
          PreveCeutical Medical ’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does PreveCeutical Medical have?
          PreveCeutical Medical has 570,649,500 shares outstanding.
            What happened to PreveCeutical Medical ’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of PreveCeutical Medical ?
            Currently, no hedge funds are holding shares in TSE:PREV

            Company Description

            PreveCeutical Medical

            PreveCeutical Medical Inc. (PREV) is a biotechnology company focused on developing innovative preventive and curative therapies utilizing both natural and synthetic compounds. The company's core offerings include cannabinoid-based therapies, sol-gel drug delivery technologies, and peptide-based therapeutics targeting various ailments. Operating at the intersection of health sciences and biotechnology, PreveCeutical aims to provide solutions that enhance health and well-being.
            Similar Stocks
            Company
            Price & Change
            Follow
            Curaleaf Holdings
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis